Perturbing DDR signaling enhances cytotoxic effects of local oncolytic virotherapy and modulates the immune environment in glioma
2022 · Molecular Therapy — Oncolytics · 39 citations
https://doi.org/10.1016/j.omto.2022.07.009
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
30
Papers
476
Citations
10
h-index
11
i10-index
Marilin Koch is an academic researcher from German Cancer Research Center. The author has contributed to research in topics: Glioma Diagnosis and Treatment & CAR-T cell therapy research & Virus-based gene therapy research. The author has an h-index of 10, co-authored 26 publications.
ORCID: 0000-0002-8335-3543https://doi.org/10.1016/j.omto.2022.07.009
https://doi.org/10.1111/ene.70529
Click to start Chat